MEDVi vs Mochi Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi and Mochi Health are tied at 7.7/10. Mochi Health is more affordable at $178/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Mochi Health for users who want a tech-forward platform with app-based tracki.

A side-by-side look at MEDVi and Mochi Health to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Mochi Health

#18 of 52

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Feature	MEDVi	Mochi Health
Our Score	7.7/10	7.7/10
Starting Price	$179/mo	$178/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who want a tech-forward platform with app-based tracking
Ranking	#20	#18
Get started	Visit MEDVi	Visit Mochi Health

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels, saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose, the most delivery options of any platform
+Registered dietitians included alongside physicians, not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago, limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Our Verdict

MEDVi and Mochi Health are closely matched with identical scores of 7.7/10. If budget is your priority, Mochi Health starts at $178/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither MEDVi nor Mochi Health feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review